VistaGen Therapeutics, Inc.
A biopharmaceutical company focused on developing and commercializing treatments for depression, social anxiety, and other central nervous system disorders. The company is developing a nasal spray that does not require systemic uptake or act directly on central nervous system neurons in the brain, resulting in fewer side effects and safety concerns. The company is based in Nevada.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 39 |
Founded | 1998 |
Financials | |
|---|---|
Market Capitalization | 103.78M |
Revenue | 1.06M |
Operating Income | -33.02M |
Operating Margin | -3103.48% |
Net Income | -29.36M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4230 / 5373 |
Sector : Healthcare | 616 / 1144 |
Industry : Biotechnology | 258 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4050 / 5565 |
Sector : Healthcare | 697 / 1182 |
Industry : Biotechnology | 370 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4034 / 5436 |
Sector : Healthcare | 573 / 1164 |
Industry : Biotechnology | 246 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4552 / 5330 |
Sector : Healthcare | 851 / 1174 |
Industry : Biotechnology | 411 / 667 |